Podcast Episode
At the heart of this vision is what Hassabis calls "radical abundance," a future where AI has effectively bottled the scientific method to tackle the world's most stubborn problems. Medicine, he says, will be unrecognisable, with AI enabling personalised treatments and potentially curing major diseases.
Hassabis is now channelling this expertise through Isomorphic Labs, a Google spinoff focused on drug discovery. The company recently unveiled its Drug Design Engine, which it claims more than doubles AlphaFold's accuracy for certain drug design predictions. By shifting from laboratory work to computer-based simulation, Hassabis believes drug discovery could become a thousand times more efficient, with clinical trials for AI-designed cancer drugs expected by the end of this year.
Looking further ahead, Hassabis envisions AI unlocking new materials for fusion and solar energy, and ultimately enabling humanity to travel beyond Earth. At the World Economic Forum in Davos last month, he reiterated his belief that artificial general intelligence has a fifty percent chance of arriving by twenty thirty.
DeepMind Chief Predicts AI-Powered Renaissance Within Fifteen Years
February 14, 2026
0:00
4:05
Google DeepMind CEO Demis Hassabis has predicted that artificial intelligence will usher in a new golden era of discovery within ten to fifteen years, transforming medicine, solving the energy crisis, and enabling space exploration. He outlined a vision of radical abundance powered by AI-driven science.
A New Renaissance on the Horizon
Sir Demis Hassabis, the Nobel Prize-winning CEO of Google DeepMind, has laid out his most ambitious vision yet for the future of artificial intelligence. Speaking on a recent podcast, Hassabis predicted that humanity will enter a "new golden era of discovery" within the next ten to fifteen years, one he compares to a modern renaissance.At the heart of this vision is what Hassabis calls "radical abundance," a future where AI has effectively bottled the scientific method to tackle the world's most stubborn problems. Medicine, he says, will be unrecognisable, with AI enabling personalised treatments and potentially curing major diseases.
From Proteins to Pills
The foundation for this bold prediction rests on proven results. AlphaFold, DeepMind's breakthrough system that cracked the decades-old protein folding problem, is now used by over three million researchers worldwide and earned Hassabis the Nobel Prize in Chemistry in twenty twenty-four.Hassabis is now channelling this expertise through Isomorphic Labs, a Google spinoff focused on drug discovery. The company recently unveiled its Drug Design Engine, which it claims more than doubles AlphaFold's accuracy for certain drug design predictions. By shifting from laboratory work to computer-based simulation, Hassabis believes drug discovery could become a thousand times more efficient, with clinical trials for AI-designed cancer drugs expected by the end of this year.
Navigating the Disruption
Hassabis acknowledged the challenges ahead, describing Google's position as a classic innovator's dilemma. The twenty twenty-three merger of Google Brain and DeepMind under his leadership was a direct response to this challenge, creating what he describes as a "nuclear power plant" plugged into Google's vast ecosystem.Looking further ahead, Hassabis envisions AI unlocking new materials for fusion and solar energy, and ultimately enabling humanity to travel beyond Earth. At the World Economic Forum in Davos last month, he reiterated his belief that artificial general intelligence has a fifty percent chance of arriving by twenty thirty.
Published February 14, 2026 at 10:11am